Uncategorized
FDA debuts plan to collect real-time clinical trial data
The FDA is launching a pilot program to collect and review clinical trial data in real time, giving scientific reviewers access to the data as it flows in, the agency announced Tuesday.
AstraZeneca and Amgen …